DeepMed Research

NATIONAL INSTITUTES OF HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary, Private

Established: 1948-01-01

Employees: 1K

Market Cap: -

Website: http://www.nidcr.nih.gov

Clinical Trials

Using X-Ray Dye to Locate Hidden Parathyroid Tumors

Completed

Conditions: Parathyroid Neoplasms

First Posted Date: 1999-11-04

Last Posted Date: 2008-03-04

Lead Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Target Recruit Count: 150

Registration Number: NCT00001394

Locations: 🇺🇸
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda, Maryland, United States

A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatric Patients With Primary and Metastatic Brain Tumors

Completed

Conditions: Brain Tumor, Primary
Brain Neoplasm
Brain Cancer

First Posted Date: 1999-11-04

Last Posted Date: 2019-05-08

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 40

Registration Number: NCT00001574

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Screening for Patients Needing Kidney, Kidney-Pancreas, or Islet-Cell Transplant

Completed

Conditions: Kidney Failure
Diabetes Mellitus

First Posted Date: 1999-11-04

Last Posted Date: 2019-12-17

Lead Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Target Recruit Count: 621

Registration Number: NCT00001859

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Methods in Education for Breast Cancer Genetics

Phase 3

Completed

Conditions: Breast Cancer
Ovarian Cancer

Interventions: Other: Genetic Education and Counseling

First Posted Date: 1999-11-04

Last Posted Date: 2019-12-12

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 170

Registration Number: NCT00001806

Locations: 🇺🇸
Walter Reed National Medical Center, Bethesda, Maryland, United States

Chemotherapy and Progenitor Cell Transplantation to Treat Inflammatory Breast Cancer

Phase 1

Completed

Conditions: Breast Neoplasm
Neoplasm Metastasis

First Posted Date: 1999-11-04

Last Posted Date: 2018-12-21

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 107

Registration Number: NCT00001507

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin With G-CSF for Patients With Newly Diagnosed Advanced Stage Ovarian Cancer

Phase 2

Completed

Conditions: Ovarian Neoplasm

First Posted Date: 1999-11-04

Last Posted Date: 2018-04-05

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 66

Registration Number: NCT00001426

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Cryptococcus Neoformans Infection in Patients Not Infected With HIV and Complications Associated With Cryptococcus Neoformans Infection

Completed

Conditions: Cryptococcosis

First Posted Date: 1999-11-04

Last Posted Date: 2017-07-02

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 300

Registration Number: NCT00001701

Locations: 🇺🇸
University of Alabama, Birmingham, Alabama, United States

Treatment of Zollinger-Ellison Syndrome

Completed

Conditions: Zollinger Ellison Syndrome

First Posted Date: 1999-11-04

Last Posted Date: 2017-07-02

Lead Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Registration Number: NCT00001241

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

(1)H-Nuclear Magnetic Resonance Spectroscopic Imaging of the Brain in Patients Who Receive Neurotoxic Therapy

Completed

Conditions: Brain Cancer
Brain Neoplasms

First Posted Date: 1999-11-04

Last Posted Date: 2019-04-24

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 50

Registration Number: NCT00001807

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Evaluation for NCI Surgery Branch Clinical Research Protocols

Recruiting

Conditions: Synovial Cell Cancer
Colorectal Cancer
Bladder Cancer
Melanoma
Lung Cancer

First Posted Date: 1999-11-04

Last Posted Date: 2025-05-11

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 7000

Registration Number: NCT00001823

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy